Huperzine A, a novel promising acetylcholinesterase inhibitor

NeuroReport

Volumn 8, Issue 1, 1997, Pages 97-101

  Cheng, Dong Hang ^a   Ren, Hua ^a   Tang, Xi Can ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Alzheimer's disease; Cholinesterase inhibitor; E2020; Huperzine A; Memory; Radial maze; Scopolamine; Tacrine

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; HUPERZINE A; SCOPOLAMINE; TACRINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MEMORY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030896029     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199612200-00020     Document Type: Article

References (22)

1. Davies P and Maloney AJF. Lancet 2, 1403 (1976).
2. Bartus RT, Dean RL, Beer B et al. Science 217, 408-417 (1982).
3. Coyle JT, Price DL and DeLong MR. Science 219, 1184-1190 (1983).
4. Perry EK, Tomlinson BE, Blessed G et al. Br Med J 2, 1457-1459 (1978).
5. Wilcock GK, Tsiri MM, Bowen DM et al. J Neurol Sci 57, 407-417 (1982).
6. Davidson M, Stern RG, Bierer LM et al. Acta Psychiatr Scand Suppl 366, 47-51 (1991).
7. Thal LJ, Masur DM, Blau AD et al. J Am Geriatr Soc 37, 42-48 (1989).
8. Summers WK, Majovski LV, Marsh GM et al. N Engl J Med 315, 1241-1245 (1986).
9. Watkins PB, Zimmerman HJ, Knapp MJ et al. JAMA 271, 991-998 (1994).
10. Thal, LJ. Physostigmine in Alzheimer's disease. In: Becker R, Giacobini E, (eds). Cholinergic Basis for Alzheimer Therapy. Cambridge: Birkhauser Boston, 1991: 209-215.
11. Liu JS, Zhu YL, Yu CM et al. Can J Chem 64, 837-839 (1986).
12. Wang YE, Yue DX and Tang XC. Acta Pharmacol Sin 7, 110-113 (1986).
13. Mckinney M, Miller JH, Yamada F et al. Eur J Pharmacol 203, 303-305 (1991).
14. Tang XC, Xiong ZQ, Qian BC et al. Cognition improvement by oral huperzine A: a novel acetylcholinesterase inhibitor. In: Giacobini E, Becker R, (eds). Alzheimer Disease: Therapeutic Strategies. Cambridge: Birkhauser Boston, 1994: 113-119.
15. Rogers SL, Yamanishi Y, Yamatsu K. E2020 - the pharmacology of poperidein cholinesterase inhibitor. In: Becker R, Giacobini E, eds. Cholinergic Basis for Alzheimer Therapy. Cambridge: Birkhauser Boston, 1991: 314-320.
16. Wrisching BA, Beninger RJ, Jhamandas K et al. Pharmacol Biochem Behav 20, 659-662 (1984).
17. Ellman GL, Courtney KD, Andre V Jr et al. Biochem Pharmacol 7, 88-95 (1961).
18. Kopelman MDQ J Exp Psychol 38A, 535-573 (1986).
19. Okaichi H, Oshima Y and Jarrard LE. Pharmacol Biochem Behav 34, 599-602 (1989).
20. Tang XC, De Sarno P, Sugaya et al. J Neurosci Res 24, 276-285 (1989).
21. Lin JH, Hu GY and Tang XC. Acta Pharmacol Sin 17, 299-301 (1996).
22. Bowen DM, Franics PT, Chessel IP et al. Trends Neurosci 17, 149-150 (1994).